Stem Cell Cryopreservation Market Growth Outlook Indicating Expansion To $10.17 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Stem Cell Cryopreservation Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The stem cell cryopreservation market size has witnessed substantial growth in recent years. It is anticipated to increase from $4.17 billion in 2025 to $4.99 billion in 2026, with a compound annual growth rate (CAGR) of 19.8%. This historical expansion can be attributed to the expansion of stem cell banking initiatives, increasing use of cryopreservation in research, growth in ivf and fertility treatments, rising demand for long-term cell storage, and improvements in cryogenic storage technologies.

The stem cell cryopreservation market is projected to observe significant expansion in the upcoming years, with its size reaching $10.17 billion by 2030, driven by a compound annual growth rate (CAGR) of 19.5%. This projected growth throughout the forecast period can be attributed to the rising acceptance of regenerative medicine therapies, increasing investments within biobanking infrastructure, a growing need for personalized medicine storage solutions, the broadening of clinical cell therapy pipelines, and a greater emphasis on standardized storage protocols. Prominent trends for the forecast period include an escalating demand for long-term stem cell storage, the increasing application of advanced cryoprotectants, wider adoption of automated cryopreservation systems, the expansion of stem cell banking services, and an enhanced focus on maintaining cell viability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30405&type=smp

What Important Drivers Are Powering The Stem Cell Cryopreservation Market Growth?

The future expansion of the stem cell cryopreservation market is anticipated to be fueled by the rising occurrence of degenerative diseases. These conditions are defined as medical ailments where the structure or function of tissues and organs gradually worsens over time, frequently resulting in a decline in normal capabilities. The heightened frequency of degenerative diseases stems from an expanding aging demographic, given that older individuals are more prone to cellular and tissue degradation, which gives rise to these conditions. Stem cell cryopreservation facilitates the extended preservation of living stem cells, offering a dependable supply for regenerative treatments aimed at mending and substituting compromised tissues in the context of degenerative diseases. An illustrative example highlights that in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported roughly 6.7 million Americans aged 65 and older were affected by Alzheimer’s dementia, a figure forecast to escalate to 13.8 million by 2060. Consequently, the growing incidence of degenerative diseases acts as a catalyst for the expansion of the stem cell cryopreservation market.

What Segment Categories Are Evaluated In The Stem Cell Cryopreservation Market Study?

The stem cell cryopreservation market covered in this report is segmented –

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell

2) By Application: Cell Freezing Media, Equipment And Consumables

3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics

Subsegments:

1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells

2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell

3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

Which Trends Are Influencing The Expansion Of The Stem Cell Cryopreservation Market?

Prominent companies within the stem cell characterization kits market are concentrating on technological breakthroughs, such as microfluidic mechanoporation, to enable effective intracellular delivery while safeguarding stem cell viability and phenotype for precise subsequent characterization. Microfluidic mechanoporation is a method that employs controlled mechanical forces within microscopic fluidic channels to temporarily breach cell membranes, thereby facilitating efficient molecule delivery into cells. For example, in July 2024, STEMCELL Technologies, a Canadian biotechnology firm, unveiled the CellPore Transfection System. This offering integrates a benchtop instrument with the CellPore Transfection Kit 300, which supplies single-use delivery cartridges and leverages rapid, controlled cell deformation within microfluidic channels to achieve mechanoporation. The system aims to accomplish efficient delivery into challenging-to-transfect and primary cells, all while upholding cell quality for downstream analyses.

Which Firms Are Competing In The Stem Cell Cryopreservation Market?

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Access The Complete Stem Cell Cryopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Which Geographic Region Represents The Largest Stem Cell Cryopreservation Market Share?

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Stem Cell Cryopreservation Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30405&type=smp

Browse Through More Reports Similar to the Global Stem Cell Cryopreservation Market 2026, By The Business Research Company

Human Embryonic Stem Cells Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report

Stem Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell And Gene Therapy Manufacturing Services Market 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795